Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
GASTRO DIAGNOSIS & RESEARCH from Ganshoren, company number BE0471786422, closed financial year 2025 with a result of € 35,614 after tax. For that financial year GASTRO DIAGNOSIS & RESEARCH recorded a gross margin of € 52,557 and equity of € 228,844. Compared with financial year 2024, the result moved from € 35,876 to € 35,614. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2026.
€ 228,844
▲ 18% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 35,614
▼ 1% vs 2024
Profit after tax over the fiscal year.
€ 115,414
▼ 7% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 143,244.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 4,738
▲ € 4,566 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,678
▼ 45% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 16,380
▲ 28% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 51,791 | € 55,217 | € 54,004 | € 52,557 | ▼ 3% |
| Profit after taxes | € 34,692 | € 35,640 | € 35,876 | € 35,614 | ▼ 1% |
| Equity | € 192,815 | € 228,455 | € 193,231 | € 228,844 | ▲ 18% |
| Total debts | € 10,713 | € 8,660 | € 83,418 | € 18,057 | ▼ 78% |
| Cash | € 85,644 | € 101,398 | € 123,639 | € 115,414 | ▼ 7% |
| Retained profit | € 107,215 | € 142,855 | € 107,631 | € 143,244 | ▲ 33% |
| Dividend | € 0 | € 0 | € 71,100 | € 0 | ▼ 100% |
| Balance sheet total | € 203,528 | € 237,115 | € 276,649 | € 246,902 | ▼ 11% |
Key figures of GASTRO DIAGNOSIS & RESEARCH, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to GASTRO DIAGNOSIS & RESEARCH?
What happened at GASTRO DIAGNOSIS & RESEARCH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 35,614 (▼ 1% vs 2024). filed late Source: NBB ↗
- Start of the company according to the CBE. KBO
In short
From € 34,692 profit in 2022 to € 35,614 profit in 2025.
Paid € 70,854 in corporate taxes since 2022.
Best year ever: 2024, with € 35,876 profit.
Paid out € 71,100 in dividends to the owners in total.
Management
Behind GASTRO DIAGNOSIS & RESEARCH is CLAUDE JONAS. CLAUDE JONAS is also behind DIGESTIVE DISEASE CENTER.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
François Beeckmansstraat 5
1083 Ganshoren
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0471.786.422
- VAT number
- BE 0471.786.422
- Registered office
- François Beeckmansstraat 5, 1083 Ganshoren
- Names & denominations
- GASTRO DIAGNOSIS & RESEARCH · G.D.R.
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 April 2000
- Peppol
- Not registered